The synergistic anticancer effects of apatinib combined with PD-L1 inhibitor on breast cancer

Danyang Han(First Affiliated Hospital of Henan University of Science and Technology), Xinshuai Wang(First Affiliated Hospital of Henan University of Science and Technology)
Research Square
March 30, 2022
10.21203/rs.3.rs-1383225/v1
Cited by 0

Related Papers

MiR-16-5p suppresses breast cancer proliferation by targeting ANLN
|BMC Cancer|2021|63